Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimating the burden of SARS-CoV-2 in France
Henrik Salje, Cécile Tran Kiem, Noémie Lefrancq, et al.
Science (2020) Vol. 369, Iss. 6500, pp. 208-211
Open Access | Times Cited: 1117

Showing 1-25 of 1117 citing articles:

Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
Seth Flaxman, Swapnil Mishra, Axel Gandy, et al.
Nature (2020) Vol. 584, Iss. 7820, pp. 257-261
Open Access | Times Cited: 3419
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jérôme Hadjadj, Nader Yatim, Laura Barnabei, et al.
Science (2020) Vol. 369, Iss. 6504, pp. 718-724
Open Access | Times Cited: 2872
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies, Sam Abbott, Rosanna C. Barnard, et al.
Science (2021) Vol. 372, Iss. 6538
Open Access | Times Cited: 2450
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
Marina Pollán, Beatriz Pérez‐Gómez, Roberto Pastor‐Barriuso, et al.
The Lancet (2020) Vol. 396, Iss. 10250, pp. 535-544
Open Access | Times Cited: 1806
Age-specific mortality and immunity patterns of SARS-CoV-2
Megan O’Driscoll, Gabriel Ribeiro dos Santos, Lin Wang, et al.
Nature (2020) Vol. 590, Iss. 7844, pp. 140-145
Open Access | Times Cited: 1155
The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries
Patrick Walker, Charles Whittaker, Oliver J. Watson, et al.
Science (2020) Vol. 369, Iss. 6502, pp. 413-422
Open Access | Times Cited: 1024
The Macroeconomics of Epidemics
Martin Eichenbaum, Sérgio Rebelo, Mathias Trabandt
(2020)
Open Access | Times Cited: 935
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Soo Lim, Jae Hyun Bae, Hyuk‐Sang Kwon, et al.
Nature Reviews Endocrinology (2020) Vol. 17, Iss. 1, pp. 11-30
Open Access | Times Cited: 925
Aging in COVID-19: Vulnerability, immunity and intervention
Yiyin Chen, Sabra L. Klein, Brian T. Garibaldi, et al.
Ageing Research Reviews (2020) Vol. 65, pp. 101205-101205
Open Access | Times Cited: 909
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study
Christian Karagiannidis, Carina Mostert, Corinna Hentschker, et al.
The Lancet Respiratory Medicine (2020) Vol. 8, Iss. 9, pp. 853-862
Open Access | Times Cited: 769
Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
Kate M. Bubar, Kyle Reinholt, Stephen M. Kissler, et al.
Science (2021) Vol. 371, Iss. 6532, pp. 916-921
Open Access | Times Cited: 765
COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics
Michaël Schwarzinger, Verity Watson, Pierre Arwidson, et al.
The Lancet Public Health (2021) Vol. 6, Iss. 4, pp. e210-e221
Open Access | Times Cited: 753
A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2
Tom Britton, Frank Ball, Pieter Trapman
Science (2020) Vol. 369, Iss. 6505, pp. 846-849
Open Access | Times Cited: 692
COVID-19 herd immunity: where are we?
Arnaud Fontanet, Simon Cauchemez
Nature reviews. Immunology (2020) Vol. 20, Iss. 10, pp. 583-584
Open Access | Times Cited: 564
Reduction in mobility and COVID-19 transmission
Pierre Nouvellet, Sangeeta Bhatia, Anne Cori, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 552
A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates
Gideon Meyerowitz‐Katz, Lea Merone
International Journal of Infectious Diseases (2020) Vol. 101, pp. 138-148
Open Access | Times Cited: 544
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies, Sam Abbott, Rosanna C. Barnard, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 515
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Jiandong Huo, Audrey Le Bas, Reinis R. Ruza, et al.
Nature Structural & Molecular Biology (2020) Vol. 27, Iss. 9, pp. 846-854
Open Access | Times Cited: 505
Epidemiology and transmission dynamics of COVID-19 in two Indian states
Ramanan Laxminarayan, Brian Wahl, ShankarReddy Dudala, et al.
Science (2020) Vol. 370, Iss. 6517, pp. 691-697
Open Access | Times Cited: 486
Non-pharmaceutical interventions during the COVID-19 pandemic: A review
Nicola Perra
Physics Reports (2021) Vol. 913, pp. 1-52
Open Access | Times Cited: 469
Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020
Timothy Russell, Joel Hellewell, Christopher I Jarvis, et al.
Eurosurveillance (2020) Vol. 25, Iss. 12
Open Access | Times Cited: 466
The Macroeconomics of Epidemics
Martin Eichenbaum, Sérgio Rebelo, Mathias Trabandt
Review of Financial Studies (2021) Vol. 34, Iss. 11, pp. 5149-5187
Open Access | Times Cited: 441
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis
Céline Louapre, Nicolas Collongues, Bruno Stankoff, et al.
JAMA Neurology (2020) Vol. 77, Iss. 9, pp. 1079-1079
Open Access | Times Cited: 439
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
Phillip Monk, Richard Marsden, Victoria Tear, et al.
The Lancet Respiratory Medicine (2020) Vol. 9, Iss. 2, pp. 196-206
Open Access | Times Cited: 428
Page 1 - Next Page

Scroll to top